LC– and CZE–ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339) in mouse plasma (Q60240442)
Jump to navigation
Jump to search
scientific article published on 21 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LC– and CZE–ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339) in mouse plasma |
scientific article published on 21 September 2011 |
Statements
LC- and CZE-ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] (KP1339) in mouse plasma (English)
Katharina Boeck
Gerrit Hermann
21 September 2011
1 reference